I’d have to say that’s pretty wishful thinking on a very, very very old PR that didn’t explain why they were evaluated at that level.
You don’t have a fake $50 a month virtual office with Regus with no sqf if you’re worth a bil. Google the business address if you want proof. They file the monthly rate in their SEC filings.
Only assets are patents. They did own a pharmaceutical plant but quickly returned it. Now why did they do that…
What are the patents worth? Only what someone will pay.
And they didn’t pay much for adva27a iirc.
Where is the uspto and fda fast tracking information?
About every PR is a one off or recycled information.
You look at the track record here and it is imo, not a good long term investment.
Market Data 
Markets 
AI
